5792
H. Rahaman et al. / Tetrahedron Letters 49 (2008) 5789–5792
H
X
O
Known
synthetic
route
HN
O
H
N
H
H
(CH2)6NH(CH2)8HN(CH2)6
H
N
7a. X = O
BH3-THF
0 °C-reflux
1.5 h
16
O
H
15. X = H2
Scheme 5.
Dubuffet, T.; Muller, O.; Simonef, S. S.; Descomhes, J.-J.; Laubie, M.; Verheuren,
T. J.; Lavielle, G. Bioorg. Med. Chem. Lett. 1996, 6, 349–352.
4. (a) Vedejs, E. In Advances in Cycloaddition; Curran, D. P., Ed.; JAI Press:
Greenwich, CT, 1988; Vol. 1, p 33; (b) Martin, S. F.; Cheavens, T. H. Tetrahedron
Lett. 1989, 30, 7017–7020; (c) Snider, B. B.; O’Hare, S. M. Tetrahedron Lett. 2001,
42, 2455–2458.
5. Ramesh, E.; Raghunathan, R. Tetrahedron Lett. 2008, 49, 1125–1128.
6. (a) Shirai, A.; Miyata, O.; Tohnai, N.; Miyata, M.; Procter, D. J.; Sucunza, D.;
Naito, T. J. Org. Chem. 2008, 73, 4464–4475; (b) Miyata, O.; Shirai, A.; Yoshino,
S.; Nakabayashi, T.; Takeda, Y.; Kiguchi, T.; Fukumoto, D.; Ueda, M.; Naito, T.
Tetrahedron 2007, 63, 10092–10117; (c) Miyata, O.; Shirai, A.; Yoshino, S.;
Takeda, Y.; Sugiura, M.; Naito, T. Synlett 2006, 893–896; (d) Takeda, Y.;
Nakabayashi, T.; Shirai, A.; Fukumoto, D.; Kiguchi, T.; Naito, T. Tetrahedron Lett.
2004, 45, 3481–3483.
Methoctramine is the prototype polyethylene tetraamine for
antagonism of muscarinic acetylcholine receptor (mAChR).13 Com-
pound 16 is a weaker antagonist than its free analogue at both
nAChR and M2 mAChR, but similarly potent at M3 mAChR. Borane
reduction of the lactam 7a produced the viable synthetic interme-
diate 15 in 70% yield.
One can easily prepare the constrained analogue of methoctr-
amine derivative 16 from the compound 15 by known synthetic
way (Scheme 5).12
In conclusion, the scope of the radical addition–cyclization–
elimination has been described. The reaction proceeds with a vari-
ety of substrates including the electron-donating and electron-
withdrawing groups. Keeping moderate yield in mind, this meth-
odology will allow the preparation of highly substituted aromatic
and heteroaromatic subunits that could be well set during the nat-
ural product synthesis. Currently, we are elaborating the reaction
sequences not only for the construction of tricyclic lactams, but
also towards the total synthesis of pyrrolidine fused natural
alkaloids.
7. For similar type of base-catalyzed cyclization reaction see: Ciganek, E. Synthesis
1995, 1311–1314.
8. Typical procedure for the RACE reaction of oxime ether 5a: To a boiling solution of
5a (270 mg, 0.79 mmol) in benzene (20 ml) was added a solution of Bu3SnH
(0.4 ml, 1.5 mmol) and AIBN (30 mg, 0.18 mmol) in benzene (10 ml) by syringe
pump under a N2 atmosphere. After being stirred at reflux for 5 h, the reaction
mixture was extracted with hexane/MeCN. The MeCN phase was concentrated
at reduced pressure and the residue was purified by flash chromatography
(hexane/AcOEt) to afford 7a (32%), 8a (30%), 4a (12%) and benzyl alcohol (22%).
Compound 7a: 1H NMR (CDCl3, 500 MHz) d: 2.19 (1H, dd, J = 17, 3.5 Hz). 2.66
(1H, dd, J = 17, 8.5 Hz), 2.92 (1H, m), 3.86 (1H, dd, J = 11.5, 9 Hz), 4.12 (1H, dd,
J = 11.5, 4.5 Hz), 4.76 (1H, d, J = 6.5 Hz), 6.54 (1H, br s), 6.90 (1H, dd, J = 8.5,
1.5 Hz), 6.97 (1H, td, J = 7.5, 1.5 Hz), 7.20 (2H, m). 13C NMR (CDCl3, 125 MHz) d:
32.8, 33.0, 50.7, 65.7, 117.7, 121.4, 121.8, 129.4, 129.6, 154.8, 176.1; HRMS
(ESI+): m/z calcd for C11H11NO2: 189.0790; found: 189.0789.
Acknowledgements
Compound 8a: 1H NMR (CDCl3, 500 MHz) d: 2.29 (1H, m), 2.54 (2H, m), 4.29
(1H, dd, J = 12, 10 Hz), 4.42 (1H, d, J = 10 Hz), 4.53 (1H, dd, J = 10, 4.5 Hz), 6.85
(1H, d, J = 9 Hz), 6.91 (1H, td, J = 7.5, 1 Hz), 7.01 (1H, br d, J = 7.5 Hz), 7.18 (2H,
m). 13C NMR (CDCl3, 125 MHz) d: 34.5, 40.1, 56.0, 69.1, 116.7, 120.3, 122.9,
123.8, 128.8, 152.5, 178.2; HRMS (ESI+): m/z calcd for C11H11NO2: 189.0790;
found: 189.0780.
We acknowledge the research Grants-in-Aid for Scientific Re-
search (B) (to T.N.) and C (to O.M.) from the Japan Society for the
Promotion of Science (JSPS) and Scientific Research on Priority
Areas (A) (to T.N.) from the Ministry of Education, Culture, Sports
and Technology. H.R. thanks the JSPS for a Research Grant and
Financial Assistance.
9. The sulfur containing compound 13 was prepared from 2-mercapto-
benzaldoxime ether according to the procedure described in Scheme 1. The
two-step yield of the compound 13 was 77% and the m-CPBA oxidation of 13
provided the compound 14 in 68% yield.
10. Miyabe, H.; Shibata, R.; Sangawa, M.; Ushiro, C.; Naito, T. Tetrahedron 1998, 54,
11431–11444.
11. 4-Chlorosalicylaldehyde 3g was prepared according to the published
procedure, see; Leonard, K.; Marugan, J. J.; Roboisson, P.; Calvo, R.; Gushue, J.
M.; Koblish, H. K.; Lattanze, J.; Zhao, S.; Cummings, M. D.; Player, M. R.;
Maroney, A. C.; Lu, T. Bioorg. Med. Chem. Lett. 2006, 16, 3463–3468.
12. Rosini, M.; Budriesi, R.; Bixel, M. G.; Bolognesi, M. L.; Chiarini, A.; Hucho, F.;
Krogsgaard-Larsen, P.; Mellor, I. R.; Minarini, A.; Tumiatti, V.; Usherwood, P. N.
R.; Melchiorre, C. J. Med. Chem. 1999, 42, 5212–5223.
References and notes
1. (a) Confalone, P. N.; Huie, E. M. J. Am. Chem. Soc. 1984, 106, 7175–7178; Smith,
L. T.; Livingouse, T. J. Org. Chem. 1983, 48, 1554–1555; Smith, L. T.; Livingouse,
T. Tetrahedron 1985, 41, 3559–3568; (c) Pearson, W. H. In Studies in Natural
Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, 1988; Vol. 1, p
317.
2. Witherup, K. M.; Ransom, R. W.; Graham, A. C.; Bernard, A. M.; Salvatore, M. J.;
Lumma, W. C.; Anderson, P. S.; Pitzenberger, S. M.; Varga, S. L. J. Am. Chem. Soc.
1995, 117, 6682–6685.
13. Melchiorre, C.; Cassinelli, A.; Quaglia, W. J. Med. Chem. 1987, 30, 201–204.
3. (a) Dubuffet, T.; Newman-Tancerdi, A.; Cussac, D.; Audinot, V.; Loutz, A.;
Millan, M. J.; Lavielle, G. Bioorg. Med. Chem. Lett. 1999, 9, 2059–2064; (b)